D-Wave, a pioneer in quantum computing, is at the forefront of developing cutting-edge annealing quantum computing technology, which is among the first quantum computing solutions in business use today, solving large scale optimization problems in diverse areas including logistics, manufacturing, retail, portfolio optimization, scheduling, and supply chain management.

PolarisQB is the first company to develop a drug discovery platform that utilizes the well-documented optimization power of today’s quantum computers. By leveraging D-Wave’s annealing quantum technologies, PolarisQB accelerates the identification and optimization of drug candidates. This collaboration pushes the boundaries of computational chemistry, making rapid and cost-effective drug discovery a reality.

Liverpool ChiroChem (LCC) is a chemistry platform, supporting drug discovery from hit identification to lead optimisation through expanding access to novel, diverse, chiral chemical space. LCC designs and synthesises screening libraries, where hits can be optimised in their parallel synthesis laboratory, facilitated by design and computational expertise

With the integration of LCC’s 3D stereo defined Ultra-Large Virtual Library (ULVL) into the QuADD platform from PolarisQB, research teams can identify candidates that are immediately available for further computational research, screening, or wet lab testing, shortening timeline from initiation to molecules ready for testing from months to weeks.

OpenFold is a non-profit consortium dedicated to advancing AI-driven research in computational structural biology. By developing free and open-source software, OpenFold seeks to democratize protein structure prediction and accelerate drug discovery. Collaborating with academic and industry leaders, the consortium builds cutting-edge technologies that enable the discovery of transformative treatments through the power of AI.

Scientist.com, the leading marketplace for outsourced research, allows scientists to communicate directly with research experts at over 4,500 global providers to design and execute complex research experiments.

Their platform simplifies the procurement process, enabling researchers to save time and resources while accelerating innovation. Through its partnerships with PolarisQB, Scientist.com marketplace users can now utilize quantum computing to create optimized molecular libraries for drug design in days rather than months.